MedTrace Logo

Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach

NCT03046173 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-02-08

No results posted yet for this study

Summary

To investigate the effects of concentrated growth factors applied in maxillary sinus floor elevation via a lateral window approach with simultaneous implant placement on repair of bone defects and new bone formation.

Conditions

  • Maxillary Sinus Disease

Interventions

OTHER

concentrated growth factors

These patients were randomly assigned to receive concentrated growth factors, hydroxyapatite and autogenous bone at bone defect sites in the experimental group.

OTHER

hydroxyapatite and autogenous bone

These patients were randomly assigned to receive hydroxyapatite and autogenous bone at bone defect sites in the control group.

Sponsors & Collaborators

  • Deyang Stomatological Hospital

    lead OTHER

Principal Investigators

  • Min Liu, MD · Deyang Stomatological Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-01-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046173 on ClinicalTrials.gov